scholarly journals Altered Aconitase 2 Activity in Huntington’s Disease Peripheral Blood Cells and Mouse Model Striatum

2017 ◽  
Vol 18 (11) ◽  
pp. 2480 ◽  
Author(s):  
Chiung-Mei Chen ◽  
Yih-Ru Wu ◽  
Kuo-Hsuan Chang
Keyword(s):  
Mouse Model ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Peripheral Blood Cells ◽  
Aconitase 2

scholarly journals RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease

2020 ◽  
Vol 11 ◽  
Author(s):  
Miguel A. Andrade-Navarro ◽  
Katja Mühlenberg ◽  
Eike J. Spruth ◽  
Nancy Mah ◽  
Adrián González-López ◽  
...  
Keyword(s):  
Gene Expression ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Trinucleotide Repeat ◽  
Neurodegenerative Disorder ◽  
Gene Expression Signature ◽  
Interferon Response ◽  
Peripheral Blood Cells

Huntington's disease (HD) is an autosomal dominantly inherited neurodegenerative disorder caused by a trinucleotide repeat expansion in the Huntingtin gene. As disease-modifying therapies for HD are being developed, peripheral blood cells may be used to indicate disease progression and to monitor treatment response. In order to investigate whether gene expression changes can be found in the blood of individuals with HD that distinguish them from healthy controls, we performed transcriptome analysis by next-generation sequencing (RNA-seq). We detected a gene expression signature consistent with dysregulation of immune-related functions and inflammatory response in peripheral blood from HD cases vs. controls, including induction of the interferon response genes, IFITM3, IFI6 and IRF7. Our results suggest that it is possible to detect gene expression changes in blood samples from individuals with HD, which may reflect the immune pathology associated with the disease.

DNA Damage Signatures in Peripheral Blood Cells as Biomarkers in Prodromal Huntington's Disease

2018 ◽  
Author(s):  
Imma Castaldo ◽  
Mariarosaria De Rosa ◽  
Antonella Romano ◽  
Candida Zuchegna ◽  
Ferdinando Squitieri ◽  
...  
Keyword(s):  
Dna Damage ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Peripheral Blood Cells

Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington’s disease patients

2008 ◽  
Vol 374 (4) ◽  
pp. 599-603 ◽  
Author(s):  
Sandra Almeida ◽  
Ana Bela Sarmento-Ribeiro ◽  
Cristina Januário ◽  
A Cristina Rego ◽  
Catarina R Oliveira
Keyword(s):  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Peripheral Blood Cells ◽  
Mitochondrial Abnormalities

DNA damage signatures in peripheral blood cells (PBMC) as biomarkers in prodromal Huntington's disease

2018 ◽  
Author(s):  
Imma Castaldo ◽  
Mariarosaria De Rosa ◽  
Antonella Romano ◽  
Candida Zuchegna ◽  
Ferdinando Squitieri ◽  
...  
Keyword(s):  
Dna Damage ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Peripheral Blood Cells

scholarly journals Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients

2016 ◽  
Vol 3 (5) ◽  
pp. 472-482 ◽  
Author(s):  
Johannes K. Ehinger ◽  
Saori Morota ◽  
Magnus J. Hansson ◽  
Gesine Paul ◽  
Eskil Elmér
Keyword(s):  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Respiratory Function ◽  
Peripheral Blood Cells ◽  
Mitochondrial Respiratory

Aberrant A 2A receptor function in peripheral blood cells in Huntington's disease

2003 ◽  
Vol 17 (14) ◽  
pp. 1-16 ◽  
Author(s):  
Katia Varani ◽  
Maria P. Abbracchio ◽  
Milena Cannella ◽  
Giuliana Cislaghi ◽  
Patrizia Giallonardo ◽  
...  
Keyword(s):  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Peripheral Blood ◽  
Blood Cells ◽  
Peripheral Blood Cells ◽  
Receptor Function

Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells

1987 ◽  
Vol 58 (03) ◽  
pp. 936-942 ◽  
Author(s):  
Lindsey A Miles ◽  
Edward F Plow
Keyword(s):  
T Cells ◽  
B Cell ◽  
Peripheral Blood ◽  
Binding Sites ◽  
Blood Cells ◽  
High Capacity ◽  
Red Cells ◽  
Peripheral Blood Cells ◽  
Cellular Functions ◽  
Fibrinolytic Proteins

SummaryGlu-plasminogen binds to platelets; the monocytoid line, U937, and the human fetal fibroblast line, GM1380 bind both plasminogen and its activator, urokinase. This study assesses the interaction of these fibrinolytic proteins with circulating human blood cells. Plasminogen bound minimally to red cells but bound saturably and reversibly to monocytes, granulocytes and lymphocytes with apparent Kd values of 0.9-1.4 μM. The interactions were of high capacity with 1.6 to 49 × 105 sites/cell and involved the lysine binding sites of plasminogen. Both T cells and non-rosetting lymphocytes and two B cell lines saturably bound plasminogen. Urokinase bound saturably to gianulocytes, monocytes, non-rosetting lymphocytes and a B cell line, but minimally to T cells, platelets and red cells. Therefore, plasminogen binding sites of high capacity, of similar affinities, and with common recognition specificities are expressed by many peripheral blood cells. Urokinase receptors are also widely distributed, but less so than plasminogen binding sites. The binding ol plasminogen and/ or urokinase to these cells may lead to generation of cell- associated proteolytic activity which contributes to a variety of cellular functions.

Sign in / Sign up

Export Citation Format

Share Document